The Australian Dental Association NSW (ADA NSW) is urging Australians taking popular GLP-1 medications such as Ozempic, Wegovy and Mounjaro to include their dentist as part of their healthcare team, warning that common side effects of these medicines may increase the risk of oral health problems.